These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

68 related articles for article (PubMed ID: 16801117)

  • 21. Platelet activity, sensitivity to agonist, and platelet--leukocyte conjugate formation after long-term exercise.
    Hilberg T; Schmidt V; Gläser D; Schammne D; Lösche W; Gabriel HH
    Platelets; 2002; 13(5-6):273-7. PubMed ID: 12189012
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Modulation of platelet and leucocyte function by a Chinese herbal formulation as compared with conventional antiplatelet agents.
    Zhao L; Gaudry L; Dunkley S; Brighton T; Guo ZX; Ye ZL; Luo RZ; Chesterman CN
    Platelets; 2008 Feb; 19(1):24-31. PubMed ID: 18231935
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Determinants of platelet conjugate formation with polymorphonuclear leukocytes or monocytes in whole blood.
    Izzi B; Pampuch A; Costanzo S; Vohnout B; Iacoviello L; Cerletti C; de Gaetano G
    Thromb Haemost; 2007 Dec; 98(6):1276-84. PubMed ID: 18064325
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Analysis of platelet alpha2-adrenergic receptor activity in stable coronary artery disease patients on dual antiplatelet therapy.
    Béres BJ; Tóth-Zsámboki E; Vargová K; László A; Masszi T; Kerecsen G; Préda I; Kiss RG
    Thromb Haemost; 2008 Nov; 100(5):829-38. PubMed ID: 18989527
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The in-vitro effect of tirofiban, glycoprotein IIb/IIIa antagonist, on various responses of porcine blood platelets.
    Ciborowski M; Tomasiak M; Rusak T; Winnicka K; Dobrzycki S
    Blood Coagul Fibrinolysis; 2008 Sep; 19(6):557-67. PubMed ID: 18685439
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Platelet PAR1 receptor density--correlation to platelet activation response and changes in exposure after platelet activation.
    Ramström S; Oberg KV; Akerström F; Enström C; Lindahl TL
    Thromb Res; 2008; 121(5):681-8. PubMed ID: 17675219
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Adenosine diphosphate-induced platelet aggregation correlates with platelet activation identified with the use of flow cytometry.
    García M; Schneider DJ
    Pathophysiol Haemost Thromb; 2008; 36(2):75-9. PubMed ID: 19127086
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Activation of leukocytes in whole blood samples by N-formyl-methionyl-leucyl-phenylalanine (FMLP) enhances platelet aggregability but not platelet P-selectin exposure and adhesion to leukocytes.
    Lösche W; Redlich H; Krause S; Heptinstall S; Spangenberg P
    Platelets; 1998; 9(3-4):219-21. PubMed ID: 16793705
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of bortezomib on platelet aggregation and ATP release in human platelets, in vitro.
    Avcu F; Ural AU; Cetin T; Nevruz O
    Thromb Res; 2008; 121(4):567-71. PubMed ID: 17910980
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Relationship between changes in platelet reactivity and changes in platelet receptor expression induced by physical exercise.
    Aurigemma C; Fattorossi A; Sestito A; Sgueglia GA; Farnetti S; Buzzonetti A; Infusino F; Landolfi R; Scambia G; Crea F; Lanza GA
    Thromb Res; 2007; 120(6):901-9. PubMed ID: 17337041
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Effect of a synthetic peptide corresponding to residues 313 to 320 of the alphaIIb subunit of the human platelet integrin alphaIIbbeta3 on carotid artery thrombosis in rabbits.
    Papamichael ND; Stathopoulou EM; Roussa VD; Tsironis LD; Kotsia AP; Stanica RM; Moussis V; Tsikaris V; Katsouras CS; Tselepis AD; Michalis LK
    J Pharmacol Exp Ther; 2009 May; 329(2):634-40. PubMed ID: 19244095
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Glycoprotein Ibalpha inhibition and ADP receptor antagonists, but not aspirin, reduce platelet thrombus formation in flowing blood exposed to atherosclerotic plaques.
    Penz SM; Reininger AJ; Toth O; Deckmyn H; Brandl R; Siess W
    Thromb Haemost; 2007 Mar; 97(3):435-43. PubMed ID: 17334511
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Measurement of platelet P-selectin for remote testing of platelet function during treatment with clopidogrel and/or aspirin.
    Fox SC; May JA; Shah A; Neubert U; Heptinstall S
    Platelets; 2009 Jun; 20(4):250-9. PubMed ID: 19440925
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Key role of platelet procoagulant activity in tissue factor-and collagen-dependent thrombus formation in arterioles and venules in vivo differential sensitivity to thrombin inhibition.
    Kuijpers MJ; Munnix IC; Cosemans JM; Vlijmen BV; Reutelingsperger CP; Egbrink MO; Heemskerk JW
    Microcirculation; 2008 May; 15(4):269-82. PubMed ID: 18464157
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Direct treatment of mouse or human blood with soluble 5'-nucleotidase inhibits platelet aggregation.
    Hart ML; Köhler D; Eckle T; Kloor D; Stahl GL; Eltzschig HK
    Arterioscler Thromb Vasc Biol; 2008 Aug; 28(8):1477-83. PubMed ID: 18511695
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of VASP-phosphorylation assay to light-transmission aggregometry in assessing inhibition of the platelet ADP P2Y12 receptor.
    Pampuch A; Cerletti C; de Gaetano G
    Thromb Haemost; 2006 Dec; 96(6):767-73. PubMed ID: 17139371
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antiplatelet effects of a Kampo medicine, Orengedokuto.
    Kimura Y; Shimizu M; Kohara S; Yoshii F; Sato H; Shinohara Y
    J Stroke Cerebrovasc Dis; 2006; 15(6):277-82. PubMed ID: 17904088
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Alteration of release and role of adenosine diphosphate and thromboxane A2 during collagen-induced aggregation of platelets from cattle with Chediak-Higashi syndrome.
    Honda N; Ohnishi K; Fujishiro T; Ikeda M; Ito K
    Am J Vet Res; 2007 Dec; 68(12):1399-406. PubMed ID: 18052747
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serotonergic mechanisms enhance platelet-mediated thrombogenicity.
    Galan AM; Lopez-Vilchez I; Diaz-Ricart M; Navalon F; Gomez E; Gasto C; Escolar G
    Thromb Haemost; 2009 Sep; 102(3):511-9. PubMed ID: 19718472
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Role of GPIIb-IIIa in platelet-monocyte and platelet-neutrophil conjugate formation in whole blood.
    Sanderson HM; Fox SC; Robbins RA; Lösche W; Spangenberg P; Heptinstall S
    Platelets; 1998; 9(3-4):245-50. PubMed ID: 16793711
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 4.